Half-year report · Q2
4531.TEDINET S100UPLV
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.2bn | 2024-04-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥12.9bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.8bn | 2023-04-01 → 2023-09-30 | Standalone | Net sales |
| Operating income | ¥484m | 2024-04-01 → 2024-09-30 | Standalone | Operating income |
| Operating income | ¥238m | 2023-04-01 → 2023-09-30 | Standalone | Operating income |
| Ordinary income | ¥437m | 2024-04-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥249m | 2023-04-01 → 2023-09-30 | Standalone | Ordinary income |
| Profit before tax | ¥447m | 2024-04-01 → 2024-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥192m | 2023-04-01 → 2023-09-30 | Standalone | Income before income taxes |
| Net income | ¥366m | 2024-04-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥776m | 2023-04-01 → 2024-03-31 | Standalone | Net income loss (5-year summary) |
| Net income | ¥170m | 2023-04-01 → 2023-09-30 | Standalone | Profit loss |
| Total assets | ¥25.2bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥24.4bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥21.6bn | at 2023-09-30 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥12.6bn | at 2024-09-30 | Standalone | Liabilities |
| Total liabilities | ¥11.9bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥12.6bn | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥12.4bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.6bn | at 2023-09-30 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥904m | at 2024-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥588m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥904m | at 2024-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥588m | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥784m | at 2023-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2023-03-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥388m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥274m | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.2bn | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.9bn | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥333m | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥419m | 2024-04-01 → 2024-09-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥948m | 2023-04-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥300m | 2023-04-01 → 2023-09-30 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥16.83 | 2024-04-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.57 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.82 | 2023-04-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥8 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Equity ratio | 50.1% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.0% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.0% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 21,974,000 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,974,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 21,974,000 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 426
| Item | Context | Value | Unit |
|---|---|---|---|
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)有機合成薬品工業株式会社 | |
| Address of shareholder treasury shares etc | CurrentQuarterInstant_Row1Member | Original text (Japanese)東京都中央区日本橋人形町三丁目10番４号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Type1 semi annual financial statements financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding promissory notes due on balance sheet date (text) | CurrentQuarterInstant_NonConsolidatedMember | Text · Plus | |
| Notes on insurance income (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | Prior1YTDDuration_NonConsolidatedMember | Original text (Japanese)ファインケミカル事業のみの単一セグメントであるため、記載を省略しております。 | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration_NonConsolidatedMember | Original text (Japanese)ファインケミカル事業のみの単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |